Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30239% above fair value

$4.54−0.12 (-2.58%)

Close on Nov 13, 2026Market cap $1.63BP/E 113.5Yield –

Precigen operating margin

Operating margin is operating income as a percentage of revenue.

Precigen's operating margin for the twelve months ending Sep 30, 2026 was 21.4%. For fiscal 2025 it was -1141.1%, against -3440.2% the year before. The highest annual figure on record is -62.8% in fiscal 2017.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-1141.1%	+2299.1
FY2024	Dec 31, 2024	-3440.2%	−1837.7
FY2023	Dec 31, 2023	-1602.5%	−1268.1
FY2018	Dec 31, 2018	-334.4%	−271.6
FY2017	Dec 31, 2017	-62.8%	+2.7
FY2016	Dec 31, 2016	-65.6%	+19.0
FY2015	Dec 31, 2015	-84.6%	+12.7
FY2014	Dec 31, 2014	-97.3%	+146.9
FY2013	Dec 31, 2013	-244.2%	+301.4
FY2012	Dec 31, 2012	-545.6%	+483.0
FY2011	Dec 31, 2011	-1028.7%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	52.1%	+1232.2
Q2 FY2026	Jun 30, 2026	41.2%	+3751.9
Q1 FY2026	Mar 31, 2026	-25.8%	+1659.2
Q4 FY2025	Dec 31, 2025	-474.6%	−292.7
Q3 FY2025	Sep 30, 2025	-1180.0%	−1082.5
Q2 FY2025	Jun 30, 2025	-3710.7%	−3671.9
Q1 FY2025	Mar 31, 2025	-1685.0%	−1629.4
Q4 FY2020	Dec 31, 2020	-181.9%	+222.3
Q3 FY2020	Sep 30, 2020	-97.6%	+92.1
Q2 FY2020	Jun 30, 2020	-38.9%	+26.6
Q1 FY2020	Mar 31, 2020	-55.6%	+129.7
Q4 FY2019	Dec 31, 2019	-404.2%	+246.7
Q3 FY2019	Sep 30, 2019	-189.6%	+4.4
Q2 FY2019	Jun 30, 2019	-65.5%	+15.9
Q1 FY2019	Mar 31, 2019	-185.3%	−71.6
Q4 FY2018	Dec 31, 2018	-650.9%	−616.5
Q3 FY2018	Sep 30, 2018	-194.1%	−96.8
Q2 FY2018	Jun 30, 2018	-81.4%	−16.6
Q1 FY2018	Mar 31, 2018	-113.7%	−55.0
Q4 FY2017	Dec 31, 2017	-34.4%	+36.5
Q3 FY2017	Sep 30, 2017	-97.2%	–
Q2 FY2017	Jun 30, 2017	-64.8%	–
Q1 FY2017	Mar 31, 2017	-58.7%	–
Q4 FY2016	Dec 31, 2016	-70.8%	–